Artiva Biotherapeutics, Inc. (ARTV) Net Margin
- 2024-03-31: Net Margin -5562.95%.
- 2023-12-31: Net Margin -673.67%.
- 2023-09-30: Net Margin 42.31%.
- 2023-06-30: Net Margin -322.68%.
Complete source-backed net margin history.
- Available history
- 2023-06-30 to 2024-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-03-31 | -5562.95% |
| 2023-12-31 | -673.67% |
| 2023-09-30 | 42.31% |
| 2023-06-30 | -322.68% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -26045.02% |
| 2023-12-31 | -87.23% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |